<PAGE>
SECURITIES AND EXCHANGE COMMISSION
450 Fifth Street, N.W.
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 0-14887
The Liposome Company, Inc.
(Exact name of registrant as specified in its charter)
One Research Way
Princeton Forrestal Center
Princeton, New Jersey, 08540
(609) 452-7060
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, par value $.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to
file reports under section 13(a)or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provisions(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) /X/ Rule 12h-3(b)(1)(ii) /_/
Rule 12g-4(a)(1)(ii) /_/ Rule 12h-3(b)(2)(i) /_/
Rule 12g-4(a)(2)(i) /_/ Rule 12h-3(b)(2)(ii) /_/
Rule 12g-4(a)(2)(ii) /_/ Rule 15d-6 /_/
Rule 12h-3(b)(1)(i) /X/
Approximate number of holders of record as of the certification or notice
date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
Date: May 12, 2000 By: /s/ Charles A. Baker
_____________________
Name: Charles A. Baker
Title: Chairman of the Board
President and Chief
Executive Officer
